$CALA I performed an exhaustive side-by-side comparison with CALA vs FTSV. Either FTSV is significantly overvalued or CALA is still severely undervalued. Primecap’s involvement will lead to additional analyst coverage and it will come from top-tier wire houses. We could be in for a protractive bullish move in stock price for Calithera. I’m not telling anyone what to do but I would be very reluctant to sell any shares under $15.00. Don’t fall prey to MM games. The best thing you could do is lapse into a coma for 6 months and then reevaluate the situation.